Literature DB >> 2474382

VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.

R Herbrecht1, J J Garcia, J P Bergerat, P Dufour, B Duclos, F Oberling.   

Abstract

A total of 20 patients with intermediate or high-grade non-Hodgkin's lymphomas who failed to LNH 84 regimen were treated with a combination of VP 16, ifosfamide and methotrexate (VIM regimen). Nineteen patients are evaluable for response. Eight patients (42%) achieved complete responses and four (21%) attained partial responses. Most of the complete responders are still in remission with a follow-up of more than 30 months for 5 patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474382     DOI: 10.1007/bf00304770

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  3 in total

1.  Results of MIME salvage regimen for recurrent or refractory lymphoma.

Authors:  F Cabanillas; F B Hagemeister; P McLaughlin; W S Velasquez; S Riggs; L Fuller; T Smith
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

2.  LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

Authors:  B Coiffier; C Gisselbrecht; R Herbrecht; H Tilly; A Bosly; N Brousse
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

3.  IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.

Authors:  F Cabanillas; F B Hagemeister; G P Bodey; E J Freireich
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.